Galina S. Zamay

Galina S. Zamay

Auto-generated profile, based on publicly available information

Galina S. Zamay

Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 December 2024 in Russian Journal of Oncology
Verified
Journal Article
Closed access
PDF file
AKAleksey V. Krat
Aleksey V. Krat
DKDaria A. Kirichenko
Daria A. Kirichenko
GZGalina S. Zamay
Galina S. Zamay
RZRuslan A. Zukov
Ruslan A. Zukov
OKOlga S. Kolovskaya
Olga S. Kolovskaya
ПСПац Юрий Степанович
Пац Юрий Степанович
BACKGROUND: Lung cancer (LC) is one of the most prevalent types of cancer, with mortality rates reaching 25% of all cancer-related deaths. The majority of patients are classified as stage IV at the time of diagnosis, a stage at which the probability of successful treatment is considerably low. Conventional diagnostic methods for lung cancer are expensive, labor-intensive, and highly invasive if a biopsy is performed. Consequently, liquid biopsy, which involves the extraction of circulating tumor cells from blood samples, has emerged as a pivotal area of research in oncology. AIM: To develop a method for the isolation and identification of circulating tumor cells in the peripheral blood of patients with lung cancer using DNA aptamers. MATERIALS AND METHODS: The study objects are lung cancer tissue, blood of patients with lung cancer and primary lung cancer cell culture. Gold-decorated magnetic nanoparticles and thiolated aptamers LC-17, LC-183 and LC-224 were used to isolate proteins. A hybrid of a thiol primer and a non-specific DNA sequence composed of two AG nucleotide repeats was used as a control. Mass spectrometry was performed using UltiMate 3000 nano-UHPLC system coupled with Orbitrap Fusion mass spectrometer (Thermo Scientific, USA). Circulating tumor cell counts were measured on CytoFLEX flow cytometer (Beckman Coulter, USA) after triple staining. Fluorescence microscopy was used for CSC visualization. RESULTS: The potential protein targets of the aptamers LC-17, LC-183, and LC-224 were identified. These aptamers were then used to isolate circulating tumor cells from the blood of patients with lung cancer. The identification of circulating tumor cells was performed using flow cytometry and fluorescence microscopy. CONCLUSIONS: The proposed method for the identification of circulating tumor cells through magnetic separation and flow cytometry provides a quantitative analysis of the target analyte, facilitated by the use of cell-specific lung cancer aptamers, including LC-17, LC-183, and LC-224, which exhibit high-affinity binding properties.

20 December 2024 in Russian Journal of Oncology
Verified
Journal Article
Open access
PDF file
GZGalina S. Zamay
Galina S. Zamay
TZTatiana N. Zamay
Tatiana N. Zamay
DCDaniil S. Chumakov
Daniil S. Chumakov
SSSemen A. Sidorov
Semen A. Sidorov
AKAleksey V. Krat
Aleksey V. Krat
ХГХлебцов Николай Григорьевич
Хлебцов Николай Григорьевич
Background: The problem of recurrence, generalization, or metastasis of lung cancer remains relevant to this day, despite the advances in diagnostic and therapeutic methods of treatment. The main method of localized lung cancer treatment is surgery. The volume of resection is determined by the location of the tumor, its spread to surrounding tissues and the status of lymph node damage. However, even after removal of a large part of the lung, metastatic foci may remain in healthy tissue. To improve the effectiveness of diagnostics during surgery, fluorescence-navigated surgery can be used, based on the use of fluorescent dyes, which enables to see even small clusters of malignant cells in the early stages of tumor process development. Aim: To develop a drug for fluorescence-navigation surgery based on aptamers and fluorescent gold nanoclusters (fluorescence excitation wavelengths are 365–410 nm, emission wavelengths are 615–650 nm). Materials and Methods: The object of the study is primary cultures of non-small cell lung cancer. Liposomes functionalized with DNA aptamer LC-17 were used to deliver gold nanoclusters stabilized with glutathione (GSH-AuNC) or bovine serum albumin (BSA-AuNC) to lung cancer cells. Electron microscopic images of the synthesized nanoclusters were obtained using transmission electron microscopy. Analysis of the efficiency of tumor cell binding to aptamer-functionalized liposomes containing nanoclusters was performed using flow cytometry Lung adenocarcinoma tissue was used to evaluate the efficiency of fluorescent nanoclusters. Results: The diameter of BSA-AuNC and GSH-AuNC nanoclusters was 1.8±0.5 nm and 1.5±0.3 nm, respectively. When exciting by light with a wavelength of 365 nm, the maximum fluorescence emission for BSA-AuNCs was 655 nm, and for GSH-AuNCs — 613 nm. The fluorescence quantum yields for BSA-AuNCs and GSH-AuNCs were 6% and 14%, respectively. LC-17 aptamer-functionalized liposomes with included GSH-AuNC and BSA-AuNC effectively bound to lung adenocarcinoma cells and stained them. Conclusion: The possibilityl of using gold nanoclusters stabilized by GSH-AuNC and BSA-AuNC for fluorescence-guided surgery is demonstrated.